Label: HAEMONETICS ANTICOAGULANT SODIUM CITRATE- trisodium citrate dihydrate solution
- NDC Code(s): 57826-420-02
- Packager: Haemonetics Corporation
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: New Drug Application
Drug Label Information
Updated February 2, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- HAEMONETICS ANTICOAGULANT SODIUM CITRATE 4% w/v SOLUTION USP
- CAUTION:
- SPL UNCLASSIFIED SECTION
- RECOMMENDED STORAGE:
- Product code
- Product Labeling
-
INGREDIENTS AND APPEARANCE
HAEMONETICS ANTICOAGULANT SODIUM CITRATE
trisodium citrate dihydrate solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:57826-420 Route of Administration EXTRACORPOREAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID 40 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:57826-420-02 250 mL in 1 BAG; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA BN980123 01/10/2013 Labeler - Haemonetics Corporation (057827420)